Bishal Gyawali

Dr. Bishal Gyawali is an Associate Professor in the Department of Oncology at Queen's University, combining clinical practice with research focused on global oncology, evidence-based medicine, and health policy. He holds an MD from the Institute of Medicine, Tribhuvan University (Nepal), a PhD in medical science from Nagoya University (Japan), and a fellowship in cancer policy from Harvard University. His work emphasizes equitable cancer care, particularly in low-resource settings.

Research interests include global oncology, cancer drug development, health economics, clinical trial design, and access to cancer treatments worldwide. He advocates for higher standards in clinical research and better regulatory practices to improve healthcare resource allocation.

• Education: MD (Tribhuvan University), PhD (Nagoya University), Cancer Policy Fellowship (Harvard)
• Clinical Focus: Breast, genitourinary (GU), and gastrointestinal (GI) malignancies
• Awards:
  • FASCO (2025)
  • Global Oncology Young Investigator Award (2021)
  • Top 40 Under 40 in Cancer (2020)

His clinical work emphasizes evidence-based practice and shared decision-making, while his research addresses global disparities in oncology education and drug accessibility. He serves on editorial boards for JAMA Oncology and BMJ Global Health, and chairs ASCO’s Value in Cancer Care Task Force.